Wondering how to best protect your patients or your own baby this winter from RSV? We'll go over the different preventative options against RSV in today's episode!

This episode was written by pediatricians Tammy Yau and Lidia Park with content support from Kenneth Yau (general pediatrics). Pediatricians Tammy and Lidia take full responsibility for any errors or misinformation.

Follow us on Twitter/X @Pediagogypod, Instagram/Threads @pediagogy, Bluesky @pediagogypodcast.bluesky.social, and connect with us at pediagogypod@gmail.com

Key Points:

• RSV immunizations can stimulate an immune response to create antibodies against RSV or can directly give antibodies to an individual
• The RSV vaccine (Abrysvo) for adults can be given to pregnant individuals to provide passive immunity to infants after birth. It should be given at 32-36 weeks of gestational and 2 weeks prior to delivery
• After birth, infants can be given an RSV immunization, either nirsevimab (Beyfortus) or clesrovimab (Enflonsia), which are RSV antibodies. These can be given to all infants less than 8 months old if the pregnant parent did not receive Abrysvo. High risk infants 8-19 months should also receive RSV immunization.

Sources:

• CDC: https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/pregnant-people.html
• AAP Oct 2025: https://doi.org/10.1542/peds.2025-073923
• AAP Patient Care: https://www.aap.org/en/patient-care/respiratory-syncytial-virus-rsv-prevention/rsv-frequently-asked-questions/?srsltid=AfmBOopMfpneGvJVfI8lZGHlZg5gtqU7AtrR2NbqYzVh9OINyVnrXqT-